Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 3.3T | 3.5T | 3.4T | 3.3T |
Cost of revenue | 2.1T | 2.2T | 2.0T | 2.1T |
Gross profit | 1.2T | 1.3T | 1.3T | 1.3T |
Operating expense | ||||
Research & development | — | 2.7B | 485.9M | — |
Selling general and admin | 520.4B | 649.8B | 543.2B | 472.4B |
Other operating expenses | -92.2B | -110.5B | 171.0B | -55.4B |
Operating income | 477.4B | 357.3B | 351.6B | 565.6B |
Non operating interest income | ||||
Income | 56.0B | 48.3B | 50.1B | 51.8B |
Expense | 16.5B | 15.4B | 15.8B | 16.6B |
Other income expense | — | — | — | — |
Pretax income | 517.8B | 387.2B | 386.4B | 599.5B |
Tax provision | 79.1B | 46.5B | 85.0B | 144.8B |
Net income | 438.6B | 340.7B | 301.4B | 454.7B |
Basic EPS | 91 | — | — | — |
Diluted EPS | 91 | — | — | — |
Basic average shares | 4.5B | — | — | — |
Diluted average shares | 4.5B | — | — | — |
EBITDA | 583.0B | 559.6B | 453.3B | 666.3B |
Net income from continuing op. | — | — | — | — |
Minority interests | -29.4B | 24.3B | -39.8B | -41.1B |
Preferred stock dividends | 0 | 0 | 0 | 0 |